Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Oral perfluorooctane sulfonate (PFOS) lessens tumor development in the APCmin mouse model of spontaneous familial adenomatous polyposis

Fig. 3

Shown is the average body weight (mean and s. e.) by dose group from 6–15 weeks of age weeks in male mice. As can be seen, body weight appeared to slow in proportion to PFOS dose. At approximately 12 weeks of age, the 200 mg/kg group stopped exhibiting weight increases altogether. Table 1 depicts the gender, dose groups, animal numbers and duration of exposure for the animals completing each study

Back to article page